Bank Of America Corp Centessa Pharmaceuticals PLC Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Bank Of America Corp holds 73,277 shares of CNTA stock, worth $1.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
73,277
Previous 76,984
4.82%
Holding current value
$1.18 Million
Previous $869,000
23.94%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CNTA
# of Institutions
84Shares Held
96.7MCall Options Held
12.1KPut Options Held
3K-
Medicxi Ventures Management (Jersey) LTD20MShares$320 Million66.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$160 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$155 Million2.77% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.71MShares$91.7 Million1.82% of portfolio
-
First Light Asset Management, LLC Edina, MN4.78MShares$76.7 Million3.93% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.51B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...